Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R K Ferguson

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
Drug Intelligence & Clinical Pharmacy|July 1, 1985
The role of beta-blocking agents following myocardial infarctionP H Vlasses, H H Rotmensch, R K Ferguson
The Medical Clinics of North America|March 1, 1988
Angiotensin-converting enzyme inhibitorsH H Rotmensch, P H Vlasses, R K Ferguson
JAMA|April 16, 1982
Clinical use of captopril. Illustrative casesR K Ferguson, H H Rotmensch, P H Vlasses
Life Sciences|December 22, 1980
Effects of captopril, diuretic, and their combination in low-renin essential hypertensionR K Ferguson, P H Vlasses, B N Swanson
Federation Proceedings|April 1, 1984
Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapyW B Abrams, R O Davies, R K Ferguson
The American Journal of Medicine|October 1, 1984
Clinical applications of angiotensin-converting enzyme inhibitorsR K Ferguson, P H Vlasses, H H Rotmensch
Rational Drug Therapy|August 1, 1984
Amiodarone: a new drug for the treatment of cardiac arrhythmiasA J Greenspon, P H Vlasses, R K Ferguson
Clinical Nephrology|October 1, 1984
Creatinine serum concentrations and H2-receptor antagonistsM L Rocci, P H Vlasses, R K Ferguson
Circulation|July 1, 1976
Patient acceptance of guanethidine as therapy for mild to moderate hypertension. A comparison with reserpineR K Ferguson, R J Rothenberg, A S Nies
Pharmacotherapy|January 1, 1989
Angiotensin-converting enzyme inhibitors: mechanistic controversiesM R Ujhelyi, R K Ferguson, P H Vlasses
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Drug Intelligence & Clinical Pharmacy|July 1, 1985
The role of beta-blocking agents following myocardial infarctionP H Vlasses, H H Rotmensch, R K Ferguson
The Medical Clinics of North America|March 1, 1988
Angiotensin-converting enzyme inhibitorsH H Rotmensch, P H Vlasses, R K Ferguson
JAMA|April 16, 1982
Clinical use of captopril. Illustrative casesR K Ferguson, H H Rotmensch, P H Vlasses
Life Sciences|December 22, 1980
Effects of captopril, diuretic, and their combination in low-renin essential hypertensionR K Ferguson, P H Vlasses, B N Swanson
Federation Proceedings|April 1, 1984
Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapyW B Abrams, R O Davies, R K Ferguson
The American Journal of Medicine|October 1, 1984
Clinical applications of angiotensin-converting enzyme inhibitorsR K Ferguson, P H Vlasses, H H Rotmensch
Rational Drug Therapy|August 1, 1984
Amiodarone: a new drug for the treatment of cardiac arrhythmiasA J Greenspon, P H Vlasses, R K Ferguson
Clinical Nephrology|October 1, 1984
Creatinine serum concentrations and H2-receptor antagonistsM L Rocci, P H Vlasses, R K Ferguson
Circulation|July 1, 1976
Patient acceptance of guanethidine as therapy for mild to moderate hypertension. A comparison with reserpineR K Ferguson, R J Rothenberg, A S Nies
Pharmacotherapy|January 1, 1989
Angiotensin-converting enzyme inhibitors: mechanistic controversiesM R Ujhelyi, R K Ferguson, P H Vlasses
Pageof 13